脂肪性肝炎
纤维化
肝纤维化
医学
非酒精性脂肪性肝炎
单核细胞
脂肪肝
内科学
非酒精性脂肪肝
疾病
作者
Oliver Krenkel,Tobias Puengel,Olivier Govaere,Ali T. Abdallah,Jana C. Mossanen,Marlene Kohlhepp,Anke Liepelt,Éric Lefebvre,Tom Luedde,Claus Hellerbrand,Ralf Weiskirchen,Thomas Longerich,Ivan G. Costa,Quentin M. Anstee,Christian Trautwein,Frank Tacke
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2017-09-21
卷期号:67 (4): 1270-1283
被引量:522
摘要
Pharmacological inhibition of CCR2+ monocyte recruitment efficiently ameliorates insulin resistance, hepatic inflammation, and fibrosis, corroborating the therapeutic potential of CVC in patients with NASH. (Hepatology 2018;67:1270-1283).
科研通智能强力驱动
Strongly Powered by AbleSci AI